CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors

Abroad (travel likely)Recruiting

Conditions

Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing cancer hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Hua Zhu) · zhuhuabch@pku.edu.cn · 010-88196495

Study leads

Hua Zhu
Principal Investigator
Peking University Cancer Hospital & Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SW-682 in Advanced Solid Tumors

Advanced Solid Tumor · Mesothelioma, Malignant

Abroad (travel likely)RecruitingPHASE1

Scottsdale, United States · Los Angeles, United States

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Solid Tumor Malignancies · Metastatic Cancer · Breast Cancer

Abroad (travel likely)Recruiting

Chapel Hill, United States

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Newport Beach, United States · Denver, United States

A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

Advanced Solid Tumors With MAPK Pathway Mutations

Abroad (travel likely)RecruitingPHASE1, PHASE2

Detroit, United States · New York, United States